Clinical Trial

A Study Of MCG In Cardiac Amyloidosis

Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this observational study is to evaluate the utility of magnetocardiography (MCG) in diagnosing and monitoring disease progression in patients with amyloidosis, and to assess its effectiveness in comparison to other modalities, such as ECG.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-10-16.
Status change: Not Yet Recruiting → Recruiting 2025-12-15
Trial Details
NCT Number NCT07218705
Lead Sponsor Mayo Clinic
Conditions Amyloidosis
Enrollment 500 participants
Start Date 2025-12-03
Primary Completion 2027-11 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2025-12-22